Mofid, Bahram, et al. “Oncological Outcomes of Neoadjuvant Gemcitabine Plus Carboplatin Versus Gemcitabine Plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant Carboplatin in Locally Advanced Bladder Cancer”. Urology Journal, vol. 19, no. 05, Nov. 2022, pp. 371-8, doi:10.22037/uj.v19i05.6841.